David Ramsey, MD, PhD, MPH, outlines why patients with diabetes should undergo regular eye examinations.
Monitoring diabetic retinopathy can prevent irreversible vision loss, said David Ramsey, MD, PhD, MPH, an ophthalmologist and director of ophthalmic research at Lahey Hospital and Medical Center of Beth Israel Lahey Health. Ramsey presented research during an American Academy of Ophthalmology 2021 conference session called "Telehealth Encourages More Minority Patients With Diabetes to Return for In-Person Care During the COVID-19 Pandemic." Research coauthors included Karen Latulippe; Jeffrey L. Marx, MD; Shiyoung Roh, MD; Claudia C. Lasalle; Sidrah Anjum; and Ed Momplaisir.
Transcript
Why is it so important patients with diabetes receive eye examinations?
Diabetic retinopathy is the leading cause of vision loss among working-age Americans. Delivering eye care, examining patients with diabetes to monitor them for the development of diabetic retinopathy, and once it's developed, monitoring it to determine the point at which it needs treatment can not only prevent irreversible vision loss, but can actually help patients to recover vision once the effects of diabetic retinopathy have begun to take their effect on the retina. We have many different therapies available now, ranging from medications that can be administered into the eye to laser therapy, that have been shown not only to prevent blindness and allow more Americans to continue working, but even reverse the effects of diabetes and the age-associated toll that it takes on the visual system.
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Joanne Mizell: Lifestyle Modification Programs Take Holistic Aim at Metabolic Disease
May 1st 2024Joanne Mizell shares insurer strategies in addressing the escalating rates of metabolic diseases, highlighting the importance of holistic treatment methods like lifestyle modification programs, which integrate nutrition, physical activity, and community engagement.
Read More